- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00123994
Tai Chi or Hydrotherapy for People With Osteoarthritis of the Hip(s) or Knee(s)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A single blinded randomized controlled clinical trial with 3 allocation groups:
- Tai Chi: maximum 15 people per group, twice weekly, 12 weeks.
- Hydrotherapy: maximum 15 people per group, twice weekly, 12 weeks.
- Control: 12 weeks waiting time prior to allocation to active intervention.
A specially designed Tai Chi program (Tai Chi for Arthritis, Paul Lam) will be provided in a community setting by trained instructors. Hydrotherapy sessions will be held at the St. George Hospital under supervision of registered physiotherapists with rheumatology and hydrotherapy experience.
Outcomes will be measured twice: 12 and 24 weeks after randomisation.
Study Type
Enrollment
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New South Wales
-
Kogarah, New South Wales, Australia, 2217
- St George Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Symptomatic osteoarthritis of the hip(s) or knee(s) according to American College of Rheumatology (ACR) clinical and radiographic (hip) criteria.
Exclusion Criteria:
- Currently participating in recreational physical activity more than twice a week.
- Unable to walk indoors for more than 10 minutes without a walking aid.
- Unable to exercise at a moderate level due to major co-morbidity.
- Incontinent, afraid of water or uncontrolled epilepsy.
- Low back pain referring to limbs.
- Joint replacement surgery in past year.
- Arthroscopic surgery or intra-articular injections in knee or hip in past 3 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Self-reported pain and function (WOMAC)
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
General health status (SF-36)
|
|
Psychological well being (DASS)
|
|
Patient global assessment (100mm visual analogue scale [VAS])
|
|
Physical performance: 50 feet walk time, stair time
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Marlene H Fransen, PhD MPH, The George Institute, University of Sydney
- Study Chair: John Edmonds, MB, BS, St George Hospital, University of NSW
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NAMCIG56
- RFP 95/0203
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.